Live Breaking News & Updates on Axonis Therapeutics Inc
Stay updated with breaking news from Axonis therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antares 230+ farewell launch to fly S.S. Laurel Clark to ISS nasaspaceflight.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nasaspaceflight.com Daily Mail and Mail on Sunday newspapers.
NASA to Discuss Science on Next Northrop Grumman Space Station Mission indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
NASA Prepares for Next Northrop Grumman International Space Station Mission Aug. 1 spacecoastdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spacecoastdaily.com Daily Mail and Mail on Sunday newspapers.
Axonis Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company advancing breakthrough research to develop therapies for neurological disorders, secured an additional $5m in funding. The round was led by Alexandria Venture Investments with participation from R3 Bio, BoxOne Ventures and Civilization Ventures and the Christopher & Dana Reeve Foundation and Spinal Research. The company intends to use the funds to advance its novel neuromodulating technology into the clinic. Led by Joanna Stanicka, PhD, CEO, and Shane Hegarty, PhD, Chief Scientific Officer, Axonis Therapeutics is advancing breakthrough research to develop therapies for neurological disorders. The company’s pipeline includes neuron-reviving therapeutics that enable an intrinsic ability of central nervous system (CNS) neurons to resist degeneration, restore excitation/inhibition balance and regenerate. The company’s targeted indications include spinal cord injury and epilepsy, as well as broa ....